New PPI launched

Clinical

New PPI launched

Rosemont Pharmaceuticals has launched omeprazole powder for oral suspension, the first PPI approved for use on a mg/kg basis, indicated in babies from one month and licensed for use with percutaneous endoscopic gastonomy (PEG) and nasograstic (NG) tubes. Available in 2mg/ml and 4mg/ml strengths, a patented pack makes constitution easy, says Rosemont. The 2mg strength has a natural vanilla flavour to improve palatability. 

Further details are available from www.rosemontpharma.com

Record my learning outcomes

Clinical

Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.

Share: